Product Information

PALIPERIDONE ER 3 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.0147 per EA under NDC 43975035003. Its NADAC has been published 341 times since May 6, 2020.

FDA first approved this application on Jun 12, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PALIPERIDONE ER 3 MG TABLET

PALIPERIDONE
$1.0147per EA

Strength

3 mg/1

NDC

43975035003

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PALIPERIDONE

Approval Type

Generic (ANDA)

FDA Application

ANDA204452

FDA Approved

6/12/2019

TE Code

AB

On Market Since

11/27/2019

Pharmacological Classes

Price Statistics

The NADAC for PALIPERIDONE ER 3 MG TABLET has been published 341 times since May 6, 2020, and over the history we have for it it has declined 87.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0147 per EA
All-time high$9.3768 (Jun 10, 2020)
All-time low$0.9120 (Aug 19, 2026)
52-week high$1.2598
52-week low$0.9120
Median price$1.9114
Average price$3.3841
Largest weekly change+62.1% (Jul 21, 2021)
Weeks tracked341
Tracking sinceMay 6, 2020

Price History

1W

0.0%

1M

+4.4%

3M

+10.2%

6M

-3.5%

1Y

-18.8%

3Y

-43.3%

5Y

-82.3%

All

-87.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PALIPERIDONE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PALIPERIDONE ER 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 3 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $1.0147 per EA (NDC 43975035003), effective Nov 11, 2026.

How has the price of PALIPERIDONE ER 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for PALIPERIDONE ER 3 MG TABLET has declined 87.8%. It has been tracked across 341 weekly CMS publications since May 6, 2020.

What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 3 MG TABLET?

Since May 6, 2020, the NADAC for PALIPERIDONE ER 3 MG TABLET has ranged from a low of $0.9120 (Aug 19, 2026) to a high of $9.3768 (Jun 10, 2020), with a median of $1.9114 per EA.

Are there cheaper alternatives to PALIPERIDONE ER 3 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PALIPERIDONE ER 3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PALIPERIDONE ER 3 MG TABLET?

PALIPERIDONE ER 3 MG TABLET (NDC 43975035003) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.